氨己烯酸片在中国上市了吗？

Infantile spasms are a refractory epilepsy syndrome, mostly caused by organic brain lesions or inherited metabolic diseases. Danish company Lundbecl stated that the U.S. FDA has approved the company's drug for the treatment of two types of refractory epilepsy: infantile spasms (IS) in children aged 1 month to 2 years old; and adult epilepsy patients with refractory complex partial seizures (CPS) in combination with other drugs. The approved dosage forms are tablets and oral liquids.

The recommended dosage of vigabatrin tablets is 3g per day, taken in divided doses. The dose should be increased according to the clinical effect at a rate of 0.5-1g per day to 4g per day (or 50mg/kg per day), which is effective for complex partial seizures of epilepsy (with or without generalized tonic-clonic seizures). Children: General usage: For children aged 3-9 years, the recommended dose is 1g per day, taken in 2 divided doses; for older children, the recommended dose is 2g per day, taken in 2 divided doses. West syndrome: Average oral dose is 100 mg/kg daily (range 50-150 mg/kg).

Depression, psychosis (more common in patients with a history of psychosis and behavioral problems), memory loss, double vision, dizziness, confusion, fatigue, drowsiness, headache, weight gain, gastrointestinal disturbances, occasional aggressive behavior, edema, and hair loss. Ataxia, paresthesias, nystagmus, nervousness, agitation, and tremors may also occur.

Are vigabatrin tablets available in China? At present, vigabatrin tablets are not on the market in China. If patients want to purchase this drug, they can choose to purchase the drug overseas, or they can choose to seek more reliable overseas medical service organizations (Medical Companion Travel) in China to help you purchase vigabatrin. It is more affordable, convenient, and very safe. For details, please consult Medical Companion Travel.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.